VDPHL01: The Oral Hair Loss Pill That Beat Minoxidil in Trials
VDPHL01 is an oral minoxidil formulation built specifically for hair loss — not a repurposed blood pressure medication, which is what oral minoxidil has technically been until now. Positive Phase 2/3 data in April 2026 makes this worth understanding before it reaches market.
Why "built for hair loss" is actually notable
Oral minoxidil has been used off-label for hair loss for years — it was originally developed and approved as a blood pressure medication, and its hair-growth effect was a well-known side effect that dermatologists began prescribing off-label at lower doses. VDPHL01 is designed and dosed specifically for hair loss from the ground up, rather than being an off-label use of an existing cardiovascular drug.
What the trial data showed
Phase 2/3 results reported in April 2026 showed positive efficacy outcomes, with the trial specifically positioning the drug as outperforming topical minoxidil on certain measures — a notable claim given topical minoxidil's decades-long status as a first-line treatment.
Strut Health From $25/mo
Offers oral minoxidil options today — ask about availability of purpose-built formulations like VDPHL01 as they reach market.
Visit Strut Health →Paid linkWhat to actually do with this now
VDPHL01 isn't broadly available yet — this is pipeline news, not a treatment you can start today. If daily topical application has been a compliance barrier for you specifically, this is worth flagging to your prescriber as something to watch for, and in the meantime, off-label oral minoxidil (already available through several telehealth providers) offers a similar no-topical-application approach today.
There's a Permanent Solution
World-class FUE hair transplants in Medellín, Colombia. Board-certified surgeons, natural results, and 60–70% less than U.S. pricing. Recovery in a city with perfect spring weather year-round.